Cystic fibrosis mortality and survival in the UK: 1947-2003 Source: Eur Respir J 2007; 29: 522-526 Year: 2007
A contemporary survival analysis of individuals with cystic fibrosis: a cohort study Source: Eur Respir J 2015; 45: 670-679 Year: 2015
The impact of genotype on clinical course of cystic fibrosis (CF) in adult patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013
Cystic fibrosis and survival to 40 years: a study of cystic fibrosis transmembrane conductance regulator function Source: Eur Respir J 2011; 37: 1076-1082 Year: 2011
Demographic and survival changes of cystic fibrosis at a CF centre over 34 years Source: Eur Respir J 2007; 30: Suppl. 51, 386s Year: 2007
ABPA syndrome (ABPAs) in CF: FEV1 decline, infectious exacerbations and BMI before and after the year of diagnosis (index year), a case control study Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014
Lung function and early abnormality of glucose tolerance (GT) in cystic fibrosis (CF) patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013
p.Leu206Trp mutation: Genotype-phenotype correlation in 23 paediatric / adults cystic fibrosis (CF) patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013
Metabolic and respiratory functioning of patients with cystic fibrosis during the years preceding death Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013
The effect of transition from a paediatric to adult cystic fibrosis (CF) centre on clinical status and hospital attendance Source: International Congress 2016 – From pleura to bronchi: new insights Year: 2016
Cystic fibrosis: coming of age Source: Annual Congress 2010 - Paediatric Year in Review Year: 2010
Cystic fibrosis patients: do they profit from altitiude residence? Source: Annual Congress 2006 - Man at altitude: benefits and risks of pre-existing respiratory impairment due to various diseases Year: 2006
The study of expectant life of St-Petersburg patients with cystic fibrosis (CF) Source: Eur Respir J 2004; 24: Suppl. 48, 617s Year: 2004
Lung function, weight, and sweat chloride responses in patients with cystic fibrosis and the G551D-CFTR mutation treated with ivacaftor: A secondary analysis Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment Year: 2013
Predicting five year outcomes in adults with cystic fibrosis: Developing a predictive scoring model Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013
Assessment of the work of breathing (sWOB) within different functional and genetic groups in patients with cystic fibrosis (CF) Source: Annual Congress 2013 –New perspectives of lung function assessment in children Year: 2013
Trends in cystic fibrosis (CF) survival in South Africa over 40 years Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021
Evaluation of annual FEV1 decline and factors associated with its accelerated deterioration in a cohort of adults with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013
The treatment burden of cystic fibrosis: a day-to-day experience with treatment as someone with cystic fibrosis Source: Breathe, 17 (1) 210013; 10.1183/20734735.0013-2021 Year: 2021
Cystic fibrosis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=234 Year: 2006